The Journal of Urology
Volume 183, Issue 5 , Pages 1848-1852, May 2010

Development, Validation and Testing of an Epidemiological Case Definition of Interstitial Cystitis/Painful Bladder Syndrome

  • Sandra H. Berry

      Affiliations

    • RAND Corp., Santa Monica, California
    • Corresponding Author InformationCorrespondence: RAND Corp., 1776 Main St., Santa Monica, California 90407 (telephone: 310-393-0411, extension 7779; FAX: 310-451-6921)
  • ,
  • Laura M. Bogart

      Affiliations

    • Children's Hospital Boston/Harvard Medical School, Boston, Massachusetts
  • ,
  • Chau Pham

      Affiliations

    • RAND Corp., Santa Monica, California
  • ,
  • Karin Liu

      Affiliations

    • RAND Corp., Santa Monica, California
  • ,
  • Leroy Nyberg

      Affiliations

    • National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland
  • ,
  • Michael Stoto

      Affiliations

    • RAND Corp., Santa Monica, California
  • ,
  • Marika Suttorp

      Affiliations

    • Georgetown University, Washington, D.C.
  • ,
  • J. Quentin Clemens

      Affiliations

    • University of Michigan Medical Center, Ann Arbor, Michigan
    • Financial interest and/or other relationship with Merck, Medtronic, Lilly and Pfizer.

Received 25 July 2009 published online 18 March 2010.

Purpose

No standard case definition exists for interstitial cystitis/painful bladder syndrome for patient screening or epidemiological studies. As part of the RAND Interstitial Cystitis Epidemiology study, we developed a case definition for interstitial cystitis/painful bladder syndrome with known sensitivity and specificity. We compared this definition with others used in interstitial cystitis/painful bladder syndrome epidemiological studies.

Materials and Methods

We reviewed the literature and performed a structured, expert panel process to arrive at an interstitial cystitis/painful bladder syndrome case definition. We developed a questionnaire to assess interstitial cystitis/painful bladder syndrome symptoms using this case definition and others used in the literature. We administered the questionnaire to 599 women with interstitial cystitis/painful bladder syndrome, overactive bladder, endometriosis or vulvodynia. The sensitivity and specificity of each definition was calculated using physician assigned diagnoses as the reference standard.

Results

No single epidemiological definition had high sensitivity and high specificity. Thus, 2 definitions were developed. One had high sensitivity (81%) and low specificity (54%), and the other had the converse (48% sensitivity and 83% specificity). These values were comparable or superior to those of other epidemiological definitions used in interstitial cystitis/painful bladder syndrome prevalence studies.

Conclusions

No single case definition of interstitial cystitis/painful bladder syndrome provides high sensitivity and high specificity to identify the condition. For prevalence studies of interstitial cystitis/painful bladder syndrome the best approach may be to use 2 definitions that would yield a prevalence range. The RAND Interstitial Cystitis Epidemiology interstitial cystitis/painful bladder syndrome case definitions, developed through structured consensus and validation, can be used for this purpose.

Key Words: urinary bladder, cystitis, interstitial, pain, epidemiology, diagnosis

Abbreviations and Acronyms: IC, interstitial cystitis, IC/PBS, IC/painful bladder syndrome, OAB, overactive bladder, RAM, RAND/UCLA Appropriateness Method, RICE, RAND Interstitial Cystitis Epidemiology

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Study received institutional review board approval.

 Supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant U10DK070234-01.

 Supplementary material for this article can be obtained at http://www.rand.org/pubs/working_papers/WR718/.

PII: S0022-5347(09)03402-8

doi:10.1016/j.juro.2009.12.103

The Journal of Urology
Volume 183, Issue 5 , Pages 1848-1852, May 2010